Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle ... nerve circuitry may contribute to disease onset and symptom development.

An intervention, which involves electrical stimulation of the sensory spinal nerves, can gradually reawaken functionally ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...

Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Not all heroes wear capes. Some use robotics to revolutionize rehabilitation by creating a wearable device – dubbed the Hero ...

A University of Newcastle research team has secured a $940,000 National Health and Medical Research Council (NHMRC) Ideas Grant to examine the role of ...